Mycobacterium abscessus subspecies abscessus infection associated with cosmetic surgical procedures: Case series

Autor: F.I. Contreras-Yametti, M.A. Jara-Palacios, C. Moreno-Izquierdo, J. Zurita
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: IDCases, Vol 22, Iss, Pp e00992-(2020)
IDCases
ISSN: 2214-2509
Popis: Highlights • Mycobacterium abscessus is a drug-resistant nontuberculous mycobacterium (NTM). • Cutaneous & subcutaneous NTM infections post-cosmetic surgery are poorly diagnosed. • Initial surgical evaluation facilitates early suspicion of M. abscessus infection. • Rapidly evolving infection & negative culture/antibiotic response are indicators. • Amikacin, imipenem, & clarithromycin combination may treat M. abscessus infection.
Background Mycobacterium abscessus is one of the most pathogenic and drug-resistant opportunistic microorganisms among the nontuberculous mycobacteria (NTM) involved in skin and soft tissue infections (SSTI) associated with cosmetic surgical procedures. However, NTM infection is often wrongly diagnosed initially causing prolonged suffering. Here is described the author’s experience working with patients who developed M. abscessus SSTI after cosmetic procedures. Methods Patients who developed NTM infection after undergoing cosmetic procedures, and who presented at the Hospital Metropolitano and Hospital Vozandes (Quito, Ecuador) between 2013–2016. A review of patient medical records was performed. Results Five patients with culture proven M. abscessus subspecies abscessus SSTI after cosmetic surgeries were identified. All patients were treated with aggressive surgical debridement and antibiotics. Conclusions A rapidly spreading wound infection presenting two or more weeks after a cosmetic procedure that fails to respond to standard antimicrobial therapy should raise suspicion for NTM infection. Samples for acid-fast bacilli smear, cultures, and PCR from infected tissue should be taken. Surgical drainage and debridement are recommended along with a long course of antibiotics. In the absence of clinical trials, a combination of amikacin, imipenem, and clarithromycin may be an adequate initial treatment for M. abscessus subspecies abscessus SSTI in immunocompetent patients.
Databáze: OpenAIRE